Enanta Pharmaceuticals Inc. (ENTA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Enanta Pharmaceuticals In...

    NASDAQ: ENTA · Real-Time Price · USD
    8.54
    -0.12 (-1.39%)
    At close: Sep 11, 2025, 3:59 PM

    Enanta Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Cash & Equivalents
    		 37.23M 85.39M 43.99M 57.21M
    Short-Term Investments
    		 210.95M 284.52M 205.24M 186.8M
    Long-Term Investments
    		 3.36M 3.97M 29.29M 108.42M
    Other Long-Term Assets
    		 94K 803K -516K -1.37M
    Receivables
    		 38.65M 39.62M 49.04M 60.83M
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 608K n/a n/a n/a
    Total Current Assets
    		 299.85M 422.79M 311.71M 319.02M
    Property-Plant & Equipment
    		 73.35M 34.71M 29.75M 10.65M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 76.8M 39.48M 63.7M 119.77M
    Total Assets
    		 376.65M 462.27M 375.41M 438.79M
    Account Payables
    		 8M 4.1M 6M 9.54M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 34.46M 35.08M 2.89M 4.2M
    Other Current Liabilities
    		 n/a n/a -2.89M -4.2M
    Total Current Liabilities
    		 57.53M 62.79M 29.83M 36.17M
    Long-Term Debt
    		 136.13M 160.85M 1.42M 1.51M
    Other Long-Term Liabilities
    		 231K 663K 454K 558K
    Total Long-Term Liabilities
    		 190.3M 182.75M 24.25M 3.19M
    Total Liabilities
    		 247.84M 245.54M 54.08M 39.36M
    Total Debt
    		 226.06M 26.51M 25.26M 5.33M
    Common Stock
    		 212K 211K 208K 202K
    Retained Earnings
    		 -323.04M -207M -73.18M 48.58M
    Comprehensive Income
    		 302K -1.17M -3.72M -382K
    Shareholders Equity
    		 128.81M 216.74M 321.33M 399.43M
    Total Investments
    		 210.95M 284.52M 234.52M 295.21M

    Add to Watchlist